A Drug Regimen for Progressive Familial Cholestasis Type 2.

Malatack JJ, Doyle D. A Drug Regimen for Progressive Familial Cholestasis Type 2. Pediatrics. 2018 01; 141(1).

View in: PubMed

Benzothiepins
Biological Transport
Carbamazepine
Child
Cholestasis, Intrahepatic
Drugs, Investigational
Genetic Predisposition to Disease
Glycosides
Humans
Male
Phenylbutyrates
Pruritus
Quality of Life
Recurrence
Risk Assessment
Siblings
Treatment Outcome

Daniel Doyle

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement